# Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

> **NCT05665920** · NA · RECRUITING · sponsor: **Instituto Brasileiro de Controle do Cancer** · enrollment: 36 (estimated)

## Conditions studied

- Malignant Breast Neoplasm

## Interventions

- **RADIATION:** Ultra-hypofractionated whole breast radiotherapy
- **RADIATION:** Standard Radiation

## Key facts

- **NCT ID:** NCT05665920
- **Lead sponsor:** Instituto Brasileiro de Controle do Cancer
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-18
- **Primary completion:** 2027-10-18
- **Final completion:** 2030-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05665920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05665920, "Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05665920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*